Skip to main content

An Opiate Lawsuit Filed By 14 Prosecutors Tossed

An Opiate Lawsuit Filed By 14 Prosecutors Tossed

An Opiate Lawsuit Filed By 14 Prosecutors Tossed

Introduction

Last month, a Tennessee judge dismissed a lawsuit that labeled Big Pharma opioid manufacturers as drug dealers of opioids. This is the result of lawsuits filed by 14 prosecutors of 47 Middle and East Tennessee counties against several opiate manufacturers and distributors in 2017.

Eighth Judicial District Circuit Court Judge John D. McAfee ruled that it was legal for drug manufacturers like Purdue Pharma to produce and market FDA-approved medications and sell them through distributors registered with The Drug Enforcement Administration (DEA). He dismissed the argument made by the prosecutors that the defendants in the opioid litigation are part of an "illegal drug market" as per Tennessee's Drug Dealer Liability Act (DDLA). The Act allows innocent third parties to sue drug dealers responsible for their damages. The "innocent third parties" mentioned in the lawsuit include opioid-addicted babies born in Tennessee’s Campbell County.

The judge wrote in his decision that, "the Court disagrees with the plaintiff's assertion that because of the Manufacturer Defendants' business and marketing practices, the otherwise legal production and distribution of opioid medications become illegal by overproducing and by the subsequent criminal conduct of other unrelated actors." The opioid crisis which was declared as a national health emergency in 2017 has affected Tennessee more than any other US state, except West Virginia. Out of 42,000 opioid deaths in 2016 in the nation, 1,186 were from Tennessee.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!